Second Quarter Fiscal 2027 Results
Roseville, Minn., October 26, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today announced results for its second quarter of fiscal 2027, the three months ended September 27, 2026. Second Quarter Fiscal Year 2027 Highlights:
(All comparisons are to the second quarter of fiscal 2026 unless otherwise noted.) • Record second quarter revenue of $313.8 million, with growth of 12%, driven by increased sales across all segments, including Water Treatment segment growth of 16%, Food & Health Sciences segment growth of 5%, and Industrial Solutions segment growth of 10%.
• Record second quarter diluted earnings per share ("EPS") of $1.34 increased $0.25, or 23%.
• Record second quarter net income of $27.8 million increased 23%, with record trailing twelve-month net income of $85.8 million. Record Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a non-GAAP measure, of $59.1 million, a 16% increase. Record trailing twelve-month adjusted EBITDA of $188.0 million.
• Generated operating cash flow of $75.5 million, an increase of 6% for the six months ended September 27, 2026 . Free cash flow, defined as net cash provided by operating activities less capital expenditures, increased 14% to $53.1 million compared to the same period in the prior year, which we allocated to repurchasing $18.6 million of stock, paying down $15.0 million of debt and paying $8.1 million in dividends.
• Closed our second acquisition of fiscal 2027 with the purchase of Dave Symonds & Associates, Inc., a blended phosphates for corrosion control and sequestration focused water distributor based in Florida.
• Subsequent to quarter end, we expanded into the Dallas–Fort Worth region, pairing our greenfield Water Treatment facility with the acquisition of Eagle Labs, Inc., a water treatment distributor with in-house manufacturing capabilities and expertise in coagulants and polymers.
Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:
“Our record second-quarter results in revenue, gross profit, EPS, and adjusted EBITDA reflect the agility of our employees and the resilience of our business model,” said Patrick Hawkins, President and Chief Executive Officer. “Revenue grew 12% in the quarter, including organic growth of 11%, with all three segments growing and Water Treatment revenue up 16%, primarily driven by increased volumes. Gross profit grew 13%, again led by Water Treatment at 20%, driven by volume growth and higher per-unit dollar margins. That gross profit growth flowed through to the bottom line, with diluted EPS up 23% and record adjusted EBITDA of $59 million, up 16%.”
Mr. Hawkins continued, “We continue to generate strong cash flow. During the quarter, we repurchased $12 million of our stock, paid down $15 million of debt, and closed on the acquisition of Dave Symonds & Associates, a tuck-in that expands our Water Treatment customer reach in Florida. Our leverage ratio at the end of the second quarter was 1.22x adjusted EBITDA, down from 1.37x at the end of fiscal 2026 and 1.54x in the same quarter last year. Subsequent to quarter end, we closed on the acquisition of Eagle Labs, which adds two locations in the Dallas–Fort Worth region, continuing our expansion in Texas. We will continue to deliver on our strategy of investing in our higher-margin businesses, acquiring companies that are accretive to Hawkins, and serving the needs of our customers to the highest level possible.”
Mr. Hawkins concluded, “Looking forward we expect the second half trends to be consistent with what we saw in the first half, recognizing that SG&A in the second half of fiscal 2026 benefited from a non-recurring $6.2 million reduction in SG&A which will not recur in the second half of fiscal 2027.”
For the second quarter of fiscal 2027, we reported net income of $27.8 million, or $1.34 per diluted share, compared to net income for the second quarter of fiscal 2026 of $22.6 million, or $1.08 per diluted share.
Sales were $313.8 million for the second quarter of fiscal 2027, an increase of $33.4 million, or 12%, from sales of $280.4 million in the same period a year ago. All of our segments grew by 5% or more from the same period a year ago. Sales increased as a result of 11% organic sales growth and approximately $3.7 million of sales from acquired businesses.
Water Treatment segment sales increased $24.1 million, or 16%, to $175.0 million for the current quarter, from $150.9 million in the same period a year ago. Organic sales grew 14%, driven primarily by increased volumes, along with improved pricing on certain of our products. Growth was broad-based across our product lines and end markets, with the municipal end market particularly strong. Acquired businesses contributed approximately $3.7 million in additional sales.
Food & Health Sciences segment sales increased $3.8 million, or 5%, to $76.7 million for the current quarter, from $72.9 million in the same period a year ago. Sales dollars increased as a result of increased volumes of our nutrition, food ingredients, and pharmaceutical products, partially offset by decreased sales of our agricultural products.
Industrial Solutions segment sales increased $5.6 million, or 10%, to $62.2 million for the current quarter, from $56.6 million in the same period a year ago. Sales increased as a result of improved pricing and favorable product mix, which more than offset lower volumes.
Gross profit increased $9.0 million, or 13%, to $76.6 million, or 24% of sales, for the current quarter, from $67.6 million, or 24% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $1.9 million due to higher raw material costs. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.3 million. The $1.6 million year-over-year impact of the unfavorable LIFO reserve was partially offset by $1.3 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The refunded tariffs related to products for which customer pricing had not been increased in response to tariffs. Gross profit was also pressured by higher fuel costs that were not fully recovered through freight charges billed to customers.
Gross profit for the Water Treatment segment increased $8.4 million, or 20%, to $51.7 million, or 30% of sales, for the current quarter, from $43.3 million, or 29% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.5 million. In the same period a year ago, the LIFO reserve decreased, and gross profit increased minimally. The $0.5 million year-over-year impact of the unfavorable LIFO reserve was more than offset by $1.2 million of refunds of previously paid tariffs, which were recorded as a reduction of cost of sales. The increase in gross profit was primarily driven by higher sales.
Gross profit for the Food & Health Sciences segment decreased $0.6 million, or 4%, to $14.9 million, or 19% of sales, for the current quarter, from $15.5 million, or 21% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.2 million. Gross profit decreased as lower margins in our food and pharmaceutical products and the $0.5 million year-over-year impact of the unfavorable LIFO reserve more than offset the benefit of higher segment sales and improved margins in our nutrition and agriculture products.
Gross profit for the Industrial Solutions segment increased $1.1 million, or 12%, to $10.0 million, or 16% of sales, for the current quarter, from $8.9 million, or 16% of sales, in the same period a year ago. During the current quarter, the LIFO reserve increased, and gross profit decreased, by $0.7 million. In the same period a year ago, the LIFO reserve increased, and gross profit decreased, by $0.1 million. The benefit of higher sales and favorable product mix was partially offset by the $0.6 million year-over-year impact of the unfavorable LIFO reserve.
Selling, general and administrative (“SG&A”) expenses increased $1.0 million, or 3%, to $34.7 million, or 11% of sales, for the three months ended September 27, 2026, from $33.7 million, or 12% of sales, in the same period a year ago. This included $0.4 million due to added costs from the acquired businesses in our Water Treatment segment. SG&A expenses also increased due to increases in other variable costs, including variable pay and other personnel costs. These increases were partially offset by a $0.5 million decrease in non-qualified deferred compensation plan expense, as appreciation in the market value of plan investments was lower than in the same period a year ago. Deferred compensation plan expense is offset by a corresponding gain on plan investments recorded in other income (expense).
Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended September 27, 2026 was $59.1 million, an increase of $8.2 million, or 16%, from $50.9 million in the same period a year ago. In the third quarter of fiscal 2026, we revised our definition of adjusted EBITDA to exclude non-cash earnout related expense and income, in order to better reflect results from operations. Prior-year adjusted EBITDA has been recast in accordance with the current definition. As originally reported, adjusted EBITDA for the three months ended September 28, 2025 was $50.4 million, which included non-cash earnout related expense that is excluded under the current definition.
Our effective income tax rate was 30% for the current quarter and 27% for the same period a year ago. The effective income tax rate for each period exceeded the U.S. federal statutory rate of 21%, primarily due to state income taxes on non-deductible expenses, including executive compensation and other permanent items. The increase in the effective income tax rate compared with prior-periods was primarily due to higher state income taxes and an increase in non-deductible items. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, state taxes and discrete items, including tax effects of stock-based compensation. Our effective tax rate for the full year is expected to be approximately 25% to 27%.
As of September 27, 2026, our working capital was $18 million higher than the end of fiscal 2026 due primarily to increased trade receivables and inventory, partially offset by an increase in payables. Our total debt outstanding at the end of the second quarter was $229.0 million, and our leverage ratio was 1.22x our trailing twelve-month adjusted EBITDA, as compared to 1.37x our trailing twelve-month adjusted EBITDA at the end of fiscal 2026.
Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for its Water Treatment, Food & Health Sciences, and Industrial Solutions customers. Headquartered in Roseville, Minnesota, the Company has 69 facilities in 28 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and has approximately 1,200 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.
We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA and free cash flow. These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.
Management uses these non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of the factors and trends affecting our financial condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation, charges for the employee stock purchase plan and restricted stock grants, non-recurring items of income or expense, and earnout related expense or income. The non-cash earnout related expense or income adjustment was added to our definition in the third quarter of fiscal 2026 to better reflect results from operations. Prior period amounts have been recast to conform to the current definition.
We define free cash flow as net cash provided by operating activities less purchases of property, plant, and equipment. Management believes free cash flow is a useful measure of the cash generated by our business that is available for, among other things, debt repayment, acquisitions, dividends, and share repurchases.
(1) Acquisition expenses consist of legal, professional, and other direct costs incurred in connection with business acquisitions. These costs are transaction- specific and not part of normal recurring operations.
September 27, March 29, 2026 2026 ────────────────────────────────────────────────────────────────────────────── ASSETS CURRENT ASSETS: Cash and cash equivalents $ 7,100 $ 3,914 Trade accounts receivables, net 149,281 139,796 Inventories 92,947 78,199 Prepaid expenses and other current 7,793 9,556 assets Total current assets 257,121 231,465 Property, plant, and equipment 509,360 489,662 Less accumulated depreciation 237,614 223,406 Net property, plant, and equipment 271,746 266,256 OTHER ASSETS: Right-of-use assets, net 17,170 16,840 Goodwill 224,439 223,042 Intangible assets, net 224,455 232,887 Deferred compensation plan asset 15,649 12,812 Other 1,472 2,988 Total other assets 483,185 488,569 Total assets $ 1,012,052 $ 986,290 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES: Accounts payable — trade $ 69,609 $ 59,835 Accrued payroll and employee benefits 15,746 20,092 Income tax payable 5,025 98 Environmental remediation 7,700 7,700 Other current liabilities 14,676 17,119 Total current liabilities 112,756 104,844 LONG-TERM LIABILITIES: Long-term debt 229,000 244,000 Long-term lease liabilities 14,699 14,457 Pension withdrawal liability 2,563 2,763 Deferred income taxes 26,143 25,110 Deferred compensation liability 16,941 14,850 Earnout liabilities 45,985 44,898 Other long-term liabilities 276 1,359 Total long-term liabilities 335,607 347,437 Total liabilities $ 448,363 $ 452,281 COMMITMENTS AND CONTINGENCIES SHAREHOLDERS' EQUITY: Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,674,812 and 20,752,138 shares issued 207 208 and outstanding as of September 27, 2026 and March 29, 2026, respectively Additional paid-in capital 14,739 32,678 Retained earnings 548,041 500,142 Accumulated other comprehensive income 702 981 Total shareholders’ equity 563,689 534,009 Total liabilities and shareholders’ $ 1,012,052 $ 986,290 equity
September 27, September 28, Six months ended 2026 2025 ────────────────────────────────────────────────────────────────────────────── CASH FLOWS FROM OPERATING ACTIVITIES: Net income $ 56,035 $ 51,773 Reconciliation to cash flows: Depreciation and 28,240 25,553 amortization Change in fair value of earnout 1,087 -1,048 liabilities Operating leases 2,121 1,881 Gain on deferred -1,689 -1,664 compensation assets Deferred income taxes 1,131 — Stock compensation 4,168 4,587 expense Other, net -60 8 Changes in operating accounts providing (using) cash: Trade receivables -9,949 5,140 Inventories -14,550 -5,196 Accounts payable 9,676 -11,013 Accrued liabilities -6,320 -4,209 Lease liabilities -2,376 -1,897 Income taxes 5,173 4,082 Other, net 2,801 3,034 Net cash provided by operating 75,488 71,031 activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property, plant, and -22,355 -24,342 equipment Acquisitions -5,200 -162,508 Proceeds from asset 517 1,037 disposals Net cash used in -27,038 -185,813 investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Cash dividends -8,136 -7,723 declared and paid New shares issued 1,681 1,609 Payroll taxes paid in exchange for -5,143 -3,028 shares withheld Shares repurchased -18,646 — Payments on senior secured revolving -20,000 -40,000 loan Payments for debt — -764 issuance costs Borrowings on senior secured revolving 5,000 170,000 loan Other -20 — Net cash (used in) provided by financing -45,264 120,094 activities NET INCREASE IN CASH AND CASH 3,186 5,312 EQUIVALENTS CASH AND CASH EQUIVALENTS, 3,914 5,103 BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF $ 7,100 $ 10,415 PERIOD SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION Cash paid for income $ 14,512 $ 13,980 taxes Cash paid for $ 5,480 $ 7,182 interest Noncash investing activities - capital $ 2,273 $ 1,568 expenditures in accounts payable
Forward-Looking Statements . Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, changes in product supplies, the availability of target acquisitions, and changes in interest rates. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended March 29, 2026 , as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements. Contacts: Jack Shufelt
Full text with the tables
Exhibit 99.1
Hawkins, Inc. Reports
Second Quarter Fiscal 2027 Results
Roseville, Minn., October 26, 2026 – Hawkins, Inc. (Nasdaq: HWKN) today
announced results for its second quarter of fiscal 2027, the three months ended
September 27, 2026.
Second Quarter Fiscal Year 2027 Highlights:
(All comparisons are to the second quarter of fiscal 2026 unless otherwise
noted.)
• Record second quarter revenue of $313.8 million, with growth of 12%, driven by
increased sales across all segments, including Water Treatment segment growth of
16%, Food & Health Sciences segment growth of 5%, and Industrial Solutions
segment growth of 10%.
• Record second quarter gross profit of $76.6 million, an increase of 13%.
• Record second quarter diluted earnings per share ("EPS") of $1.34 increased
$0.25, or 23%.
• Record second quarter net income of $27.8 million increased 23%, with record
trailing twelve-month net income of $85.8 million. Record Adjusted Earnings
Before Interest, Taxes, Depreciation and Amortization (“adjusted EBITDA”), a
non-GAAP measure, of $59.1 million, a 16% increase. Record trailing twelve-month
adjusted EBITDA of $188.0 million.
• Generated operating cash flow of $75.5 million, an increase of 6% for the six
months ended September 27, 2026 . Free cash flow, defined as net cash provided
by operating activities less capital expenditures, increased 14% to $53.1
million compared to the same period in the prior year, which we allocated to
repurchasing $18.6 million of stock, paying down $15.0 million of debt and
paying $8.1 million in dividends.
• Closed our second acquisition of fiscal 2027 with the purchase of Dave Symonds
& Associates, Inc., a blended phosphates for corrosion control and sequestration
focused water distributor based in Florida.
• Subsequent to quarter end, we expanded into the Dallas–Fort Worth region,
pairing our greenfield Water Treatment facility with the acquisition of Eagle
Labs, Inc., a water treatment distributor with in-house manufacturing
capabilities and expertise in coagulants and polymers.
Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and
President:
“Our record second-quarter results in revenue, gross profit, EPS, and adjusted
EBITDA reflect the agility of our employees and the resilience of our business
model,” said Patrick Hawkins, President and Chief Executive Officer. “Revenue
grew 12% in the quarter, including organic growth of 11%, with all three
segments growing and Water Treatment revenue up 16%, primarily driven by
increased volumes. Gross profit grew 13%, again led by Water Treatment at 20%,
driven by volume growth and higher per-unit dollar margins. That gross profit
growth flowed through to the bottom line, with diluted EPS up 23% and record
adjusted EBITDA of $59 million, up 16%.”
Mr. Hawkins continued, “We continue to generate strong cash flow. During the
quarter, we repurchased $12 million of our stock, paid down $15 million of debt,
and closed on the acquisition of Dave Symonds & Associates, a tuck-in that
expands our Water Treatment customer reach in Florida. Our leverage ratio at the
end of the second quarter was 1.22x adjusted EBITDA, down from 1.37x at the end
of fiscal 2026 and 1.54x in the same quarter last year. Subsequent to quarter
end, we closed on the acquisition of Eagle Labs, which adds two locations in the
Dallas–Fort Worth region, continuing our expansion in Texas. We will continue to
deliver on our strategy of investing in our higher-margin businesses, acquiring
companies that are accretive to Hawkins, and serving the needs of our customers
to the highest level possible.”
Mr. Hawkins concluded, “Looking forward we expect the second half trends to be
consistent with what we saw in the first half, recognizing that SG&A in the
second half of fiscal 2026 benefited from a non-recurring $6.2 million reduction
in SG&A which will not recur in the second half of fiscal 2027.”
Second Quarter Financial Highlights:
NET INCOME
For the second quarter of fiscal 2027, we reported net income of $27.8 million,
or $1.34 per diluted share, compared to net income for the second quarter of
fiscal 2026 of $22.6 million, or $1.08 per diluted share.
REVENUE
Sales were $313.8 million for the second quarter of fiscal 2027, an increase of
$33.4 million, or 12%, from sales of $280.4 million in the same period a year
ago. All of our segments grew by 5% or more from the same period a year ago.
Sales increased as a result of 11% organic sales growth and approximately $3.7
million of sales from acquired businesses.
Water Treatment segment sales increased $24.1 million, or 16%, to $175.0 million
for the current quarter, from $150.9 million in the same period a year ago.
Organic sales grew 14%, driven primarily by increased volumes, along with
improved pricing on certain of our products. Growth was broad-based across our
product lines and end markets, with the municipal end market particularly
strong. Acquired businesses contributed approximately $3.7 million in additional
sales.
Food & Health Sciences segment sales increased $3.8 million, or 5%, to $76.7
million for the current quarter, from $72.9 million in the same period a year
ago. Sales dollars increased as a result of increased volumes of our nutrition,
food ingredients, and pharmaceutical products, partially offset by decreased
sales of our agricultural products.
Industrial Solutions segment sales increased $5.6 million, or 10%, to $62.2
million for the current quarter, from $56.6 million in the same period a year
ago. Sales increased as a result of improved pricing and favorable product mix,
which more than offset lower volumes.
GROSS PROFIT
Gross profit increased $9.0 million, or 13%, to $76.6 million, or 24% of sales,
for the current quarter, from $67.6 million, or 24% of sales, in the same period
a year ago. During the current quarter, the LIFO reserve increased, and gross
profit decreased, by $1.9 million due to higher raw material costs. In the same
period a year ago, the LIFO reserve increased, and gross profit decreased, by
$0.3 million. The $1.6 million year-over-year impact of the unfavorable LIFO
reserve was partially offset by $1.3 million of refunds of previously paid
tariffs, which were recorded as a reduction of cost of sales. The refunded
tariffs related to products for which customer pricing had not been increased in
response to tariffs. Gross profit was also pressured by higher fuel costs that
were not fully recovered through freight charges billed to customers.
Gross profit for the Water Treatment segment increased $8.4 million, or 20%, to
$51.7 million, or 30% of sales, for the current quarter, from $43.3 million, or
29% of sales, in the same period a year ago. During the current quarter, the
LIFO reserve increased, and gross profit decreased, by $0.5 million. In the same
period a year ago, the LIFO reserve decreased, and gross profit increased
minimally. The $0.5 million year-over-year impact of the unfavorable LIFO
reserve was more than offset by $1.2 million of refunds of previously paid
tariffs, which were recorded as a reduction of cost of sales. The increase in
gross profit was primarily driven by higher sales.
Gross profit for the Food & Health Sciences segment decreased $0.6 million, or
4%, to $14.9 million, or 19% of sales, for the current quarter, from $15.5
million, or 21% of sales, in the same period a year ago. During the current
quarter, the LIFO reserve increased, and gross profit decreased, by $0.7
million. In the same period a year ago, the LIFO reserve increased, and gross
profit decreased, by $0.2 million. Gross profit decreased as lower margins in
our food and pharmaceutical products and the $0.5 million year-over-year impact
of the unfavorable LIFO reserve more than offset the benefit of higher segment
sales and improved margins in our nutrition and agriculture products.
Gross profit for the Industrial Solutions segment increased $1.1 million, or
12%, to $10.0 million, or 16% of sales, for the current quarter, from $8.9
million, or 16% of sales, in the same period a year ago. During the current
quarter, the LIFO reserve increased, and gross profit decreased, by $0.7
million. In the same period a year ago, the LIFO reserve increased, and gross
profit decreased, by $0.1 million. The benefit of higher sales and favorable
product mix was partially offset by the $0.6 million year-over-year impact of
the unfavorable LIFO reserve.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
Selling, general and administrative (“SG&A”) expenses increased $1.0 million, or
3%, to $34.7 million, or 11% of sales, for the three months ended September 27,
2026, from $33.7 million, or 12% of sales, in the same period a year ago. This
included $0.4 million due to added costs from the acquired businesses in our
Water Treatment segment. SG&A expenses also increased due to increases in other
variable costs, including variable pay and other personnel costs. These
increases were partially offset by a $0.5 million decrease in non-qualified
deferred compensation plan expense, as appreciation in the market value of plan
investments was lower than in the same period a year ago. Deferred compensation
plan expense is offset by a corresponding gain on plan investments recorded in
other income (expense).
ADJUSTED EBITDA
Adjusted EBITDA, a non-GAAP financial measure, is an important performance
indicator and a key compliance measure under the terms of our credit agreement.
An explanation of the computation of adjusted EBITDA is presented below.
Adjusted EBITDA for the three months ended September 27, 2026 was $59.1 million,
an increase of $8.2 million, or 16%, from $50.9 million in the same period a
year ago. In the third quarter of fiscal 2026, we revised our definition of
adjusted EBITDA to exclude non-cash earnout related expense and income, in order
to better reflect results from operations. Prior-year adjusted EBITDA has been
recast in accordance with the current definition. As originally reported,
adjusted EBITDA for the three months ended September 28, 2025 was $50.4 million,
which included non-cash earnout related expense that is excluded under the
current definition.
INCOME TAXES
Our effective income tax rate was 30% for the current quarter and 27% for the
same period a year ago. The effective income tax rate for each period exceeded
the U.S. federal statutory rate of 21%, primarily due to state income taxes on
non-deductible expenses, including executive compensation and other permanent
items. The increase in the effective income tax rate compared with prior-periods
was primarily due to higher state income taxes and an increase in non-deductible
items. The effective tax rate is impacted by projected levels of annual taxable
income, permanent items, state taxes and discrete items, including tax effects
of stock-based compensation. Our effective tax rate for the full year is
expected to be approximately 25% to 27%.
BALANCE SHEET
As of September 27, 2026, our working capital was $18 million higher than the
end of fiscal 2026 due primarily to increased trade receivables and inventory,
partially offset by an increase in payables. Our total debt outstanding at the
end of the second quarter was $229.0 million, and our leverage ratio was 1.22x
our trailing twelve-month adjusted EBITDA, as compared to 1.37x our trailing
twelve-month adjusted EBITDA at the end of fiscal 2026.
About Hawkins, Inc.
Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty
ingredients company that formulates, manufactures, distributes, and blends
products for its Water Treatment, Food & Health Sciences, and Industrial
Solutions customers. Headquartered in Roseville, Minnesota, the Company has 69
facilities in 28 states and creates value for its customers through superb
customer service and support, quality products and personalized applications.
Hawkins, Inc. generated approximately $1.1 billion of revenue in fiscal 2026 and
has approximately 1,200 employees. For more information, including registering
to receive email alerts, please visit www.hawkinsinc.com/investors.
Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with U.S. generally
accepted accounting principles (GAAP). To assist investors in understanding our
financial performance between periods, we have provided certain financial
measures not computed according to GAAP, including adjusted EBITDA and free cash
flow. These non-GAAP financial measures are not meant to be considered in
isolation or as a substitute for comparable GAAP measures. The method we use to
produce non-GAAP results is not computed according to GAAP and may differ from
the methods used by other companies.
Management uses these non-GAAP financial measures internally to understand,
manage and evaluate our business and to make operating decisions. Management
believes that these non-GAAP financial measures reflect an additional way of
viewing aspects of our operations that, when viewed with our GAAP results,
provide a more complete understanding of the factors and trends affecting our
financial condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the impact of the
following: net interest expense resulting from our net borrowing position;
income tax expense; non-cash expenses including amortization of intangibles,
depreciation, charges for the employee stock purchase plan and restricted stock
grants, non-recurring items of income or expense, and earnout related expense or
income. The non-cash earnout related expense or income adjustment was added to
our definition in the third quarter of fiscal 2026 to better reflect results
from operations. Prior period amounts have been recast to conform to the current
definition.
We define free cash flow as net cash provided by operating activities less
purchases of property, plant, and equipment. Management believes free cash flow
is a useful measure of the cash generated by our business that is available for,
among other things, debt repayment, acquisitions, dividends, and share
repurchases.
Trai…
Three Sep… Sept… Six Sept… Sep… Twel… Sep…
Adj… (In mont… 27, 28, mon… 27, 28, mont… 27,
EBI… tho… ended 2026 2025 end… 2026 2025 ended 2026
──────────────────────────────────────────────────────────────────────────────
Net
Inc… $ 27,… $ 22,5… $ 56,0… $ 51,… $ 85,…
(GA…
Int…
exp… 2,6… 3,832 5,416 7,1… 11,…
net
Inc…
tax 11,… 8,231 20,8… 18,… 30,…
exp…
Amo…
of 5,5… 5,527 11,0… 10,… 21,…
int…
Dep… 8,7… 7,735 17,2… 15,… 33,…
exp…
Non…
com… 1,9… 2,375 4,168 4,5… 8,1…
exp…
Non…
acq… 140 70 203 940 501
exp…
Non…
ear…
rel… 552 535 1,087 -1,… -4,…
exp…
(in…
Adj… $ 59,… $ 50,9… $ 115,… $ 106… $ 188…
EBI…
(1) Acquisition expenses consist of legal, professional, and other direct costs
incurred in connection with business acquisitions. These costs are transaction-
specific and not part of normal recurring operations.
Free Cash September
Flow (In Six months September 27, 28,
Reconciliat… thousands) ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net cash
provided by $ 75,488 $ 71,031
operating
activities
Less:
Purchases of
property, -22,355 -24,342
plant &
equipment
Free cash $ 53,133 $ 46,689
flow
HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
Three Septem… Septem… Six Septem… Septemb…
months 27, 28, months 27, 28,
ended 2026 2025 ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
Sales $ 313,817 $ 280,434 $ 629,492 $ 573,706
Cost
of -237,2… -212,7… -478,8… -433,701
sales
Gross 76,606 67,643 150,613 140,005
profit
Selli…
gener…
and -34,700 -33,703 -70,035 -64,732
admin…
expen…
Opera… 41,906 33,940 80,578 75,273
income
Inter…
expen… -2,643 -3,832 -5,416 -7,101
net
Other 264 721 1,689 1,663
income
Income
before 39,527 30,829 76,851 69,835
income
taxes
Income
tax -11,746 -8,231 -20,816 -18,062
expen…
Net $ 27,781 $ 22,598 $ 56,035 $ 51,773
income
Weigh…
avera…
number
of 20,710… 20,737… 20,743… 20,727,…
shares
outst…
-
basic
Weigh…
avera…
number
of 20,783… 20,845… 20,827… 20,837,…
shares
outst…
-
dilut…
Basic
earni… $ 1.34 $ 1.09 $ 2.70 $ 2.50
per
share
Dilut…
earni… $ 1.34 $ 1.08 $ 2.69 $ 2.48
per
share
Cash
divid…
decla… $ 0.20 $ 0.19 $ 0.39 $ 0.37
per
common
share
HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
September 27, March 29,
2026 2026
──────────────────────────────────────────────────────────────────────────────
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 7,100 $ 3,914
Trade accounts receivables, net 149,281 139,796
Inventories 92,947 78,199
Prepaid expenses and other current 7,793 9,556
assets
Total current assets 257,121 231,465
Property, plant, and equipment 509,360 489,662
Less accumulated depreciation 237,614 223,406
Net property, plant, and equipment 271,746 266,256
OTHER ASSETS:
Right-of-use assets, net 17,170 16,840
Goodwill 224,439 223,042
Intangible assets, net 224,455 232,887
Deferred compensation plan asset 15,649 12,812
Other 1,472 2,988
Total other assets 483,185 488,569
Total assets $ 1,012,052 $ 986,290
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable — trade $ 69,609 $ 59,835
Accrued payroll and employee benefits 15,746 20,092
Income tax payable 5,025 98
Environmental remediation 7,700 7,700
Other current liabilities 14,676 17,119
Total current liabilities 112,756 104,844
LONG-TERM LIABILITIES:
Long-term debt 229,000 244,000
Long-term lease liabilities 14,699 14,457
Pension withdrawal liability 2,563 2,763
Deferred income taxes 26,143 25,110
Deferred compensation liability 16,941 14,850
Earnout liabilities 45,985 44,898
Other long-term liabilities 276 1,359
Total long-term liabilities 335,607 347,437
Total liabilities $ 448,363 $ 452,281
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS' EQUITY:
Common stock; authorized:
60,000,000 shares of $0.01 par value;
20,674,812 and 20,752,138 shares issued 207 208
and outstanding as of September 27, 2026
and March 29, 2026, respectively
Additional paid-in capital 14,739 32,678
Retained earnings 548,041 500,142
Accumulated other comprehensive income 702 981
Total shareholders’ equity 563,689 534,009
Total liabilities and shareholders’ $ 1,012,052 $ 986,290
equity
HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
September 27, September 28,
Six months ended 2026 2025
──────────────────────────────────────────────────────────────────────────────
CASH FLOWS FROM
OPERATING ACTIVITIES:
Net income $ 56,035 $ 51,773
Reconciliation to
cash flows:
Depreciation and 28,240 25,553
amortization
Change in fair value
of earnout 1,087 -1,048
liabilities
Operating leases 2,121 1,881
Gain on deferred -1,689 -1,664
compensation assets
Deferred income taxes 1,131 —
Stock compensation 4,168 4,587
expense
Other, net -60 8
Changes in operating
accounts providing
(using) cash:
Trade receivables -9,949 5,140
Inventories -14,550 -5,196
Accounts payable 9,676 -11,013
Accrued liabilities -6,320 -4,209
Lease liabilities -2,376 -1,897
Income taxes 5,173 4,082
Other, net 2,801 3,034
Net cash provided by
operating 75,488 71,031
activities
CASH FLOWS FROM
INVESTING ACTIVITIES:
Purchases of
property, plant, and -22,355 -24,342
equipment
Acquisitions -5,200 -162,508
Proceeds from asset 517 1,037
disposals
Net cash used in -27,038 -185,813
investing activities
CASH FLOWS FROM
FINANCING ACTIVITIES:
Cash dividends -8,136 -7,723
declared and paid
New shares issued 1,681 1,609
Payroll taxes paid in
exchange for -5,143 -3,028
shares withheld
Shares repurchased -18,646 —
Payments on senior
secured revolving -20,000 -40,000
loan
Payments for debt — -764
issuance costs
Borrowings on senior
secured revolving 5,000 170,000
loan
Other -20 —
Net cash (used in)
provided by financing -45,264 120,094
activities
NET INCREASE IN CASH
AND CASH 3,186 5,312
EQUIVALENTS
CASH AND CASH
EQUIVALENTS, 3,914 5,103
BEGINNING OF
PERIOD
CASH AND CASH
EQUIVALENTS, END OF $ 7,100 $ 10,415
PERIOD
SUPPLEMENTAL
DISCLOSURES OF CASH
FLOW
INFORMATION
Cash paid for income $ 14,512 $ 13,980
taxes
Cash paid for $ 5,480 $ 7,182
interest
Noncash investing
activities - capital $ 2,273 $ 1,568
expenditures in
accounts payable
HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)
Three
mont…
ended
Sept… Food &
27, Water Health Indus…
2026: Treat… Scien… Solut… Total
──────────────────────────────────────────────────────────────────────────────
Sales $ 174,9… $ 76,679 $ 62,177 $ 313,8…
Cost
of
sales -104,… -57,3… -49,2… -211,…
-
mate…
Cost
of
sales -18,8… -4,432 -2,923 -26,1…
-
oper…
over…
Gross 51,749 14,897 9,960 76,606
prof…
Sell…
gene…
and -23,4… -7,941 -3,282 -34,7…
admi…
expe…
Oper… 28,272 6,956 6,678 41,906
inco…
Three
mont…
ended
Sept…
28,
2025:
Sales $ 150,9… $ 72,914 $ 56,612 $ 280,4…
Cost
of
sales -88,8… -53,1… -45,1… -187,…
-
mate…
Cost
of
sales -18,8… -4,280 -2,580 -25,6…
-
oper…
over…
Gross 43,261 15,481 8,901 67,643
prof…
Sell…
gene…
and -22,0… -8,084 -3,548 -33,7…
admi…
expe…
Oper… 21,190 7,397 5,353 33,940
inco…
Six
mont…
ended
Sept…
27,
2026:
Sales $ 333,2… $ 173,9… $ 122,3… $ 629,4…
Cost
of
sales -198,… -130,… -97,1… -426,…
-
mate…
Cost
of
sales -37,1… -9,062 -5,961 -52,1…
-
oper…
over…
Gross 97,245 34,172 19,196 150,6…
prof…
Sell…
gene…
and -47,1… -15,9… -6,919 -70,0…
admi…
expe…
Oper… 50,098 18,203 12,277 80,578
inco…
Six
mont…
ended
Sept…
28,
2025:
Sales $ 300,4… $ 162,0… $ 111,1… $ 573,7…
Cost
of
sales -177,… -118,… -87,9… -384,…
-
mate…
Cost
of
sales -35,4… -8,295 -4,994 -48,7…
-
oper…
over…
Gross 87,008 34,829 18,168 140,0…
prof…
Sell…
gene…
and -41,1… -16,4… -7,111 -64,7…
admi…
expe…
Oper… 45,852 18,364 11,057 75,273
inco…
Forward-Looking Statements . Various remarks in this press release constitute
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. These statements include those relating to consumer demand for
products containing our ingredients and the impacts of those demands,
expectations for results in our business segments and the timing of our filings
with the Securities and Exchange Commission. These statements are not historical
facts, but rather are based on our current expectations, estimates and
projections, and our beliefs and assumptions. Forward-looking statements may be
identified by terms, including “anticipate,” “believe,” “can,” “could,”
“expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of
these terms or other comparable terms. These statements are not guarantees of
future performance and are subject to certain risks, uncertainties and other
factors, some of which are beyond our control and are difficult to predict.
Actual results may vary materially from those contained in forward looking
statements based on a number of factors, including, but not limited to, changes
in competition and price pressures, changes in demand and customer requirements
or processes for our products, availability of product and disruptions to
supplies, interruptions in production resulting from hazards, transportation
limitations or other extraordinary events outside our control that may
negatively impact our business or the supply chains in which we participate,
changes in imported products and tariff levels, the availability of products and
the prices at which they are available, the acceptance of new products by our
customers and the timing of any such acceptance, changes in product supplies,
the availability of target acquisitions, and changes in interest rates.
Additional information concerning potential factors that could affect future
financial results is included in our Annual Report on Form 10-K for the fiscal
year ended March 29, 2026 , as updated from time to time in amendments and
subsequent reports filed with the SEC. Investors should take such risks into
account when making investment decisions. Shareholders and other readers are
cautioned not to place undue reliance on forward-looking statements, which
reflect our management’s view only as of the date hereof. We do not undertake
any obligation to update any forward-looking statements.
Contacts: Jack Shufelt
Investor Relations, Mergers and Acquisitions and Treasury Director
612/617-8582
[email protected]
[email protected]